Skip to main content
Acta Crystallographica Section E: Crystallographic Communications logoLink to Acta Crystallographica Section E: Crystallographic Communications
. 2026 Sep 3;82(Pt 10):1107–1111. doi: 10.1107/S2056989026008819

Synthesis, crystal structure and Hirshfeld surface analysis of 3-[5-(4-chloro­phen­yl)-2-sulfanyl­idene-1,3,4-oxa­diazol-3-yl]-3-(4-methyl­phen­yl)-1-(thio­phen-2-yl)propan-1-one

Shailakshi Jain a, Sharatha Kumar a,*, Tuncer Hökelek b
Editor: C Schulzkec
PMCID: PMC13638010  PMID: 42836223

The asymmetric unit of the title mol­ecule contains a planar oxa­diazole, a thio­phene and two phenyl rings. In the crystal, π–π stacking inter­actions and C—H⋯π(ring) inter­actions help to consolidate the packing.

Keywords: 4-oxa­diazol, 4-chloro­phen­yl, crystal structure

Abstract

The title thio­phene-chalcone derivative, C22H17ClN2O2S2, contains a planar oxa­diazole, a thio­phene and two phenyl rings. The dihedral angle between the oxa­diazole and thio­phene rings is 27.45 (10)°, and they are oriented with respect to the chloro­phenyl and methyl­phenyl rings at 22.61 (10), 67.07 (8) and 49.16 (10), 87.22 (8)°, respectively, while the phenyl rings are oriented at 51.78 (9)°. In the crystal, π–π stacking inter­actions and C—H⋯π(ring) inter­actions help to consolidate the packing. Hirshfeld surface analysis revealed that the most important contributions to the crystal packing are from H⋯H (31.6%), H⋯C/C⋯H (20.0%), H⋯S/S⋯H (14.2%) and H⋯O/O⋯H (9.5%) inter­actions.

1. Chemical context

Oxa­diazole is an important structural motif in medicinal chemistry for its role as a pharmacophore and a ligand-binding scaffold (Boström et al., 2012 ▸). Among its four isomeric forms, the 1,3,4-oxa­diazole ring has attracted considerable attention owing to its broad spectrum of biological activities (Salahuddin et al., 2017 ▸; Patel et al., 2014 ▸). Numerous 1,3,4- and 1,2,4-oxa­diazole derivatives have been reported to exhibit anti­bacterial, anti-inflammatory, anti­tubercular, anti-HIV, anti­fungal, cathepsin K inhibitory, mono­amine oxidase inhib­itory, anti­diabetic, tyrosinase inhibitory, anti­oxidant and anti­cancer activities (Palaska et al., 2002 ▸; Kadi et al., 2007 ▸; Alisi et al., 2020 ▸).

In recent years, thio­phene-containing chalcone derivatives have emerged as an important class of compounds because of their extended π-conjugated systems and promising applications in medicinal and materials chemistry (Shalaby et al., 2023 ▸). Adding heterocyclic moieties to the chalcone scaffold is a well-established approach for modulating mol­ecular geometry and physicochemical properties. In this context, the integration of a 1,3,4-oxa­diazole ring with a thio­phene-chalcone framework generates conjugated mol­ecular systems of significant structural and potential biological inter­est. As part of our ongoing research on heterocyclic compounds, the title thio­phene-chalcone derivative containing a 1,3,4-oxa­diazole unit was synthesized and its crystal structure was elucidated to investigate its mol­ecular conformation and inter­molecular inter­actions governing the crystal packing. Herein, we report the mol­ecular and crystal structures together with a Hirshfeld surface (HS) analysis of the title compound.1.

2. Structural commentary

The title thio­phene-chalcone derivative contains a planar oxa­diazole, a thio­phene and two phenyl rings (Fig. 1 ▸). The phenyl [A (C1–C6) and D (C16–C21)], oxa­diazole [B (O1/N1/N2/C7/C8)], and thio­phene [C (S2/C12–C15)] rings are oriented at dihedral angles of A/B = 22.61 (10)°, A/C = 49.16 (10)°, A/D = 51.78 (9)°, B/C = 27.45 (10)°, B/D = 67.07 (8)° and C/D = 87.22 (8)°. The chlorine atom Cl1 is displaced by −0.0389 (11) Å from the plane of the phenyl ring A. Atoms C22 and C9 are only −0.003 (4) Å and −0.002 (3) Å away from phenyl ring D. Atoms S1 and C9 are −0.0433 (9) Å and 0.002 (3) Å distant from the oxa­diazole, B, ring plane, while atom C11 resides 0.016 (3) Å above the thio­phene, C, ring plane. The specified atoms are, hence, essentially coplanar with the planes of the rings they are attached to. The bond lengths (Allen et al., 1987 ▸) and angles are all within normal ranges.

Figure 1.

Figure 1

The asymmetric unit with atom-numbering scheme and 50% probability ellipsoids.

3. Supra­molecular features

In the crystal, the thio­phene-to-thio­phene contacts form pairs, which are arranged along the c-axis direction, and adjacent pairs are also essentially arranged in front and behind in the a-axis direction, albeit slightly displaced with regard to the b-axis direction. The chloro­phenyl-to-chloro­phenyl contacts also form pairs with contacts arranged along the a-axis direction. However, none of these pairs has further contacts that would extend into columns, ribbons or layers (Fig. 2 ▸). The π–π stacking inter­actions involve parallel chloro­phenyl rings A and approximately parallel thio­phene rings C. The centroid-to-centroid distances are 3.6612 (18) Å [dihedral angle = 0.00 (16)° slippage = 1.466 Å] and 3.844 (3) Å [dihedral angle = 2.0 (2)°; slippage = 0.871 Å], respectively. Together with the two C—H⋯π(ring) inter­actions (Table 1 ▸), these contacts help consolidate the overall packing.

Figure 2.

Figure 2

A partial packing diagram viewed down the b–axis direction.

Table 1. Hydrogen-bond geometry (Å, °).

Cg3 and Cg4 are the centroids of the C1–C6 and C16–C21 rings.

D—H⋯A D—H H⋯A D⋯A D—H⋯A
C20—H20⋯Cg3i 0.93 2.83 3.726 (3) 164
C22—H22B⋯Cg4ii 0.96 2.92 3.671 (4) 136

Symmetry codes: (i) Inline graphic; (ii) Inline graphic.

The inter­molecular inter­actions in the crystal were further visualized through a Hirshfeld surface (HS) analysis using CrystalExplorer 17.5 (Spackman et al., 2021 ▸). Fig. 3 ▸ shows the Hirshfeld surface for the title mol­ecule plotted over dnorm. The white surface indicates contacts with distances equal to the sum of van der Waals radii, and the red and blue colours indicate distances shorter and longer than the van der Waals radii, respectively. The π–π stackings and the two C—H⋯π(ring) inter­actions are indicated in Fig. 4 ▸a,b by the presence of adjacent red and blue triangles, and Fig. 4 ▸c,d by the presence of red π-holes, respectively.

Figure 3.

Figure 3

View of the three-dimensional Hirshfeld surface for the title mol­ecule plotted over dnorm in the range from −0.2794 to 1.6393 a.u.

Figure 4.

Figure 4

Four orientations of the shape-index showing (a) and (b) the π–π and (c) and (d) the C—H⋯π(ring) inter­actions.

The overall two-dimensional fingerprint plot is shown in Fig. 5 ▸a and those delineated into H⋯H, H⋯C/C⋯H, H⋯S/S⋯H, H⋯O/O⋯H, H⋯Cl/Cl⋯H, C⋯C, C⋯Cl/Cl⋯C, C⋯S/S⋯C, O⋯S/S⋯O, H⋯N/N⋯H, Cl⋯Cl, O⋯Cl/Cl⋯O, N⋯Cl/Cl⋯N, N⋯S/S⋯N, C⋯O/O⋯C, O⋯O, N⋯O/O⋯N and C⋯N/N⋯C inter­actions are illustrated in Fig. 5 ▸(b)–(t), respectively. According to the two-dimensional fingerprint plots the H⋯H, H⋯C/C⋯ H, H⋯S/S⋯H and H⋯O/O⋯H contacts make the most significant contributions to the Hirshfeld surface, at 31.6%, 20.0%, 14.2% and 9.5%, respectively (Fig. 5 ▸).

Figure 5.

Figure 5

The full two-dimensional fingerprint plots for the title mol­ecule, showing (a) all inter­actions, and delineated into (b) H⋯H, (c) H⋯C/C⋯H, (d) H⋯ S/S⋯H, (e) H⋯O/O⋯H, (f) H⋯Cl/Cl⋯H, (g) C⋯C, (h) C⋯Cl/Cl⋯C, (i) C⋯S/S⋯C, (j) O⋯S/S⋯O, (k) H⋯N/N⋯H, (l) Cl⋯Cl, (m) O⋯Cl/Cl⋯O, (n) N⋯Cl/Cl⋯N, (o) N⋯S/S⋯N, (p) C⋯O/O⋯C, (r) O⋯O, (s) N⋯O/O⋯N and (t) C⋯N/N⋯ C inter­actions. The di and de values are the closest inter­nal and external distances (in Å) from given points on the Hirshfeld surface.

4. Database survey

A search of the Cambridge Structural Database (CSD, Version 6.01, updated February 2026; Groom et al., 2016 ▸) revealed that the crystal structure of the title compound has not been reported previously. However, with the exclusion of metal containing structures, ten structurally related compounds containing both thio­phene and 1,3,4-oxa­diazole-2(3H)-thione moieties were identified. These are N-[2-(2-thien­yl)-1-(5-thioxo-4,5-di­hydro-1,3,4-oxa­diazol-2-yl)vin­yl]benzamide (CSD refcode ENOPEE; Sharma et al., 2016 ▸), 5-(2-thien­yl)-1,3,4-oxa­diazole-2(3H)-thione (FUSDII; Burcu Arslan et al., 2014 ▸), N-[1-(5-sulfanyl­idene-4,5-di­hydro-1,3,4-oxa­diazol-2-yl)-2-(2-thien­yl)vin­yl]acetamide (HAJHAF; Karanth et al., 2019 ▸), 4-methyl-N-[1-(5-sulfanyl­idene-4,5-di­hydro-1,3,4-oxa­diazol-2-yl)-2-(thio­phen-2-yl)ethen­yl]benzamide (HAJHOT; Karanth et al., 2019 ▸), 3-[(4-phenyl­piperazin-1-yl)meth­yl]-5-(2-thien­yl)-1,3,4-oxa­diazole-2(3H)-thione (IDOBUA; El-Emam et al., 2013 ▸), 3-[(4-phenyl­piperidin-1-yl)meth­yl]-5-(thio­phen-2-yl)-1,3,4-oxa­diazole-2(3H)-thione (MURSAX; Al-Wahaibi et al., 2025 ▸), 3-{[4-(4-fluoro­phen­yl)piperazin-1-yl]meth­yl}-5-(2-thien­yl)-1,3,4-oxa­diazole-2(3H)-thione (MUXBAK; Al-Omary et al., 2015a ▸), 3-{[4-(2-meth­oxy­phen­yl)piperazin-1-yl]meth­yl}-5-(2-thien­yl)-1,3,4-oxa­dia­zole-2(3H)-thione (NUZJUP; Al-Alshaikh et al., 2016 ▸), 3-[(4-benzyl­piperazin-1-yl)meth­yl]-5-(2-thien­yl)-1,3,4-oxa­diazole-2(3H)-thione (VUBYUO; Al-Omary et al., 2015b ▸), and 3-{[meth­yl(phen­yl)amino]­meth­yl}-5-(2-thien­yl)-1,3,4-oxa­dia­zole-2(3H)-thione (ZAPJIL; El-Emam et al., 2012 ▸). Notably, in only three of these structures are the thio­phene and oxa­diazole moieties not directly linked to each other (ENOPEE, HAJHAF, HAJHOT). Two of these mol­ecules have only the two planar ring systems which comprised the search criteria (FUSDII and HAJHAF), the other eight all have a single additional phenyl ring while none consists of four planar ring systems as the title compound does.

Further thio­phene-bearing mol­ecules with structural features resembling those of the title compound include (E)-1-(2-amino­phen­yl)-3-(thio­phen-2-yl)prop-2-en-1-one (AFAXUC; Chantrapromma et al., 2013 ▸), 1-(4-amino­phen­yl)-3-(thio­phen-2-yl)prop-2-en-1-one (ROTNUN; da Silva et al., 2024 ▸), 1-[3-(4-meth­oxy- phen­yl)sydnon-4-yl]-3-(thio­phen-2-yl)prop-2-en-1-one (EVAWIH; Shih, 2004 ▸), (E)-1-(1H-pyrrol-2-yl)-3-(thio­phen-2-yl) prop-2-en-1-one (RUFLEM; Sweeting et al., 2020 ▸), (2E)-1-(4-bromo­phen­yl)-3-(thio­phen-2-yl)prop-2-en-1-one (GENXED01; Arshad et al., 2017 ▸) and 1-(4-meth­oxy­phen­yl)-3-(thio­phen-2-yl)prop-2-en-1-one (ZOV­POS; Pugh et al., 2019 ▸). In addition, compounds incorporating related 1,3,4-oxa­diazole frameworks were also found, including 4-hy­droxy-3-{[5-(pyridin-3-yl)-1,3,4-oxa­diazol-2-yl]sulfan­yl}pent-3-en-2-one (CARJIS; Zhang et al., 2021 ▸), 5-(4-meth­oxy­phen­yl)-1,3,4-oxa­diazol-2-yl­methanone (DIPGUI; Bhukta et al., 2023 ▸) and 1-(4-chloro­phen­yl)-2-{[5-(4-chloro­phen­yl)-1,3,4-oxa­diazol-2-yl]sulfan­yl}ethan-1-one (GAVMOI; Kumar et al., 2017 ▸).

5. Synthesis and crystallization

Methyl 4-chloro­benzoate (15 ml, 0.10 mol) was refluxed with hydrazine hydrate (6 ml, 0.12 mol) in ethanol (10 ml) for 4 h. The reaction mixture was cooled and poured into ice-cold water. The resulting solid was filtered, washed with water and dried to afford 4-chloro­benzohydrazide (91%, m.p. 428 K). 4-Chloro­benzohydrazide (3.41 g, 0.02 mol) was then treated with KOH (0.02 mol) and carbon di­sulfide (0.04 mol) in ethanol under reflux for 4 h. The reaction mixture was cooled, acidified with dilute HCl, and the precipitated solid was filtered, washed with water, and recrystallized from ethanol to furnish 5-(4-chloro­phen­yl)-1,3,4-oxa­diazole-2-thiol (83%, m.p. 503 K). Subsequently, 5-(4-chloro­phen­yl)-1,3,4-oxa­diazole-2-thiol was refluxed with the (2Z)-3-(4-methyl­phen­yl)-1-(thio­phen-2-yl)prop-2-en-1-one in ethanol for 4 h. After completion of the reaction, the mixture was cooled and poured into ice-cold water. The precipitated product was filtered, washed thoroughly with water, dried, and recrystallized from ethanol to afford 3-[5-(4-chloro­phen­yl)-2-thioxo-1,3,4-oxa­diazol-3(2H)-yl]-3-(4-methyl­phen­yl)-1-(thio­phen-2-yl) propan-1-one as a pure solid in 80% yield (m.p. 433 K). IR (KBr) cm−1: 1645 (C=O str.), 1594 (C=N str.), 1214 (C=S str.) and 3069 (Ar. C—H str.).

6. Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. The C-bound hydrogen-atom positions were calculated geometrically at distances of 0.93 Å (for aromatic CH), 0.98 Å (for methine CH), 0.97 Å (for methyl­ene CH) and 0.96 Å (for methyl CH) and refined using a riding model by applying the constraint of Uiso(H) = k × Ueq(C), where k = 1.5 for methyl H atoms and k = 1.2 for the other H atoms. Four reflections, 0 2 0, −2 0 2, 0 0 2 and −1 1 2, were omitted, the first three being affected by the beam stop and the fourth being a clear outlier.

Table 2. Experimental details.

Crystal data
Chemical formula C22H17ClN2O2S2
M r 440.94
Crystal system, space group Monoclinic, C2/c
Temperature (K) 300
a, b, c (Å) 20.7798 (3), 13.1963 (4), 16.1047 (4)
β (°) 102.440 (3)
V (Å3) 4312.49 (19)
Z 8
Radiation type Mo Kα
μ (mm−1) 0.39
Crystal size (mm) 0.35 × 0.25 × 0.18
 
Data collection
Diffractometer Bruker D8 Venture Diffractometer
No. of measured, independent and observed [I > 2σ(I)] reflections 53818, 3823, 2660
R int 0.117
(sin θ/λ)max (Å−1) 0.597
 
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.051, 0.133, 1.06
No. of reflections 3823
No. of parameters 263
H-atom treatment H-atom parameters constrained
Δρmax, Δρmin (e Å−3) 0.21, −0.34

Computer programs: APEX4, SAINT and XPREP (Bruker, 2021 ▸), SHELXT2018/2 (Sheldrick, 2015a ▸), SHELXL2018/3 (Sheldrick, 2015b ▸) and ORTEP-3 for Windows and WinGX publication routines (Farrugia, 2012 ▸).

Supplementary Material

Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S2056989026008819/yz2084sup1.cif

e-82-01107-sup1.cif (1.6MB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989026008819/yz2084Isup2.hkl

e-82-01107-Isup2.hkl (305.3KB, hkl)
e-82-01107-Isup3.cml (7.5KB, cml)

Supporting information file. DOI: 10.1107/S2056989026008819/yz2084Isup3.cml

CCDC reference: 2583252

Additional supporting information: crystallographic information; 3D view; checkCIF report

Acknowledgments

The authors thank the Yenepoya Deemed to be University for the facilities and financial support. TH is also grateful to Hacettepe University Scientific Research Project Unit (grant No. 013 D04 602 004). The authors’ contributions are as follows. Conceptualization, SJ, SK and TH; synthesis, SJ; X-ray analysis, SJ, SK and TH; Hirshfeld surface analysis, TH; writing (review and editing of the manuscript), SJ, SK and TH; supervision, TH and SK.

supplementary crystallographic information

3-[5-(4-Chlorophenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]-3-(4-methylphenyl)-1-(thiophen-2-yl)propan-1-one. Crystal data

C22H17ClN2O2S2 F(000) = 1824
Mr = 440.94 Dx = 1.358 Mg m−3
Monoclinic, C2/c Mo Kα radiation, λ = 0.71073 Å
a = 20.7798 (3) Å Cell parameters from 9893 reflections
b = 13.1963 (4) Å θ = 2.9–24.4°
c = 16.1047 (4) Å µ = 0.39 mm−1
β = 102.440 (3)° T = 300 K
V = 4312.49 (19) Å3 Block, colourless
Z = 8 0.35 × 0.25 × 0.18 mm

3-[5-(4-Chlorophenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]-3-(4-methylphenyl)-1-(thiophen-2-yl)propan-1-one. Data collection

Bruker D8 Venture Diffractometer Rint = 0.117
φ and ω scans θmax = 25.1°, θmin = 3.4°
53818 measured reflections h = −24→24
3823 independent reflections k = −15→15
2660 reflections with I > 2σ(I) l = −19→19

3-[5-(4-Chlorophenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]-3-(4-methylphenyl)-1-(thiophen-2-yl)propan-1-one. Refinement

Refinement on F2 0 restraints
Least-squares matrix: full Hydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.051 H-atom parameters constrained
wR(F2) = 0.133 w = 1/[σ2(Fo2) + (0.0485P)2 + 5.5114P] where P = (Fo2 + 2Fc2)/3
S = 1.06 (Δ/σ)max < 0.001
3823 reflections Δρmax = 0.21 e Å−3
263 parameters Δρmin = −0.34 e Å−3

3-[5-(4-Chlorophenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]-3-(4-methylphenyl)-1-(thiophen-2-yl)propan-1-one. Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

3-[5-(4-Chlorophenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]-3-(4-methylphenyl)-1-(thiophen-2-yl)propan-1-one. Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
Cl1 −0.02304 (5) 0.68488 (8) 0.36140 (7) 0.0940 (4)
S1 0.21099 (4) 0.09611 (6) 0.55083 (6) 0.0646 (3)
S2 0.51040 (4) 0.33068 (8) 0.88521 (6) 0.0716 (3)
O1 0.15497 (9) 0.27611 (14) 0.50923 (12) 0.0492 (5)
O2 0.40086 (11) 0.20490 (18) 0.79037 (17) 0.0766 (7)
N1 0.19842 (11) 0.37647 (17) 0.61720 (14) 0.0444 (6)
N2 0.22459 (11) 0.27964 (17) 0.62889 (14) 0.0433 (6)
C1 0.03143 (15) 0.5946 (3) 0.4151 (2) 0.0606 (9)
C2 0.04901 (17) 0.5143 (3) 0.3706 (2) 0.0698 (10)
H2 0.032596 0.509239 0.312306 0.084*
C3 0.09082 (16) 0.4415 (3) 0.41243 (19) 0.0586 (8)
H3 0.102859 0.386888 0.382601 0.070*
C4 0.11520 (13) 0.4497 (2) 0.49971 (18) 0.0459 (7)
C5 0.09805 (14) 0.5322 (2) 0.54302 (19) 0.0497 (7)
H5 0.115268 0.538910 0.601040 0.060*
C6 0.05581 (15) 0.6043 (2) 0.5010 (2) 0.0548 (8)
H6 0.043768 0.659303 0.530460 0.066*
C7 0.15780 (13) 0.3708 (2) 0.54492 (17) 0.0435 (7)
C8 0.19816 (14) 0.2172 (2) 0.56537 (18) 0.0460 (7)
C9 0.27418 (13) 0.2523 (2) 0.70549 (17) 0.0437 (7)
H9 0.294754 0.188761 0.693418 0.052*
C10 0.32768 (14) 0.3332 (2) 0.72144 (19) 0.0506 (7)
H10A 0.337773 0.353284 0.667709 0.061*
H10B 0.311617 0.392485 0.746326 0.061*
C11 0.38986 (14) 0.2951 (2) 0.78047 (19) 0.0508 (7)
C12 0.43695 (14) 0.3706 (2) 0.82279 (19) 0.0526 (8)
C13 0.43258 (19) 0.4740 (3) 0.8214 (3) 0.0882 (13)
H13 0.396509 0.510482 0.791966 0.106*
C14 0.4906 (3) 0.5181 (4) 0.8709 (4) 0.126 (2)
H14 0.497143 0.587718 0.877001 0.151*
C15 0.5353 (2) 0.4492 (3) 0.9083 (3) 0.0953 (14)
H15 0.575662 0.465943 0.943140 0.114*
C16 0.24206 (13) 0.2332 (2) 0.77969 (17) 0.0424 (6)
C17 0.24210 (15) 0.1367 (2) 0.81390 (19) 0.0488 (7)
H17 0.262005 0.083791 0.790687 0.059*
C18 0.21309 (15) 0.1179 (2) 0.8818 (2) 0.0542 (8)
H18 0.213774 0.052413 0.903324 0.065*
C19 0.18314 (14) 0.1939 (2) 0.91841 (19) 0.0498 (7)
C20 0.18410 (17) 0.2903 (2) 0.8847 (2) 0.0639 (9)
H20 0.164964 0.343337 0.908721 0.077*
C21 0.21262 (17) 0.3099 (2) 0.8164 (2) 0.0597 (8)
H21 0.211976 0.375448 0.795043 0.072*
C22 0.15170 (17) 0.1746 (3) 0.9930 (2) 0.0653 (9)
H22A 0.104615 0.174914 0.974141 0.098*
H22B 0.164729 0.226663 1.034900 0.098*
H22C 0.165739 0.109833 1.017591 0.098*

3-[5-(4-Chlorophenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]-3-(4-methylphenyl)-1-(thiophen-2-yl)propan-1-one. Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
Cl1 0.0765 (7) 0.0946 (7) 0.1055 (8) 0.0220 (6) 0.0074 (6) 0.0429 (6)
S1 0.0683 (6) 0.0478 (5) 0.0757 (6) −0.0032 (4) 0.0109 (5) −0.0161 (4)
S2 0.0460 (5) 0.0927 (7) 0.0693 (6) −0.0034 (4) −0.0026 (4) 0.0089 (5)
O1 0.0486 (12) 0.0504 (12) 0.0448 (11) −0.0060 (9) 0.0013 (9) −0.0091 (9)
O2 0.0548 (14) 0.0589 (15) 0.105 (2) 0.0017 (11) −0.0062 (13) 0.0120 (14)
N1 0.0457 (13) 0.0436 (13) 0.0407 (13) −0.0005 (11) 0.0023 (11) −0.0026 (10)
N2 0.0441 (13) 0.0417 (13) 0.0417 (13) −0.0007 (10) 0.0044 (11) −0.0039 (10)
C1 0.0454 (18) 0.063 (2) 0.071 (2) 0.0015 (15) 0.0070 (16) 0.0187 (18)
C2 0.066 (2) 0.088 (3) 0.0461 (19) 0.006 (2) −0.0075 (17) 0.0044 (18)
C3 0.058 (2) 0.070 (2) 0.0438 (18) 0.0051 (16) 0.0020 (15) −0.0057 (15)
C4 0.0380 (16) 0.0526 (17) 0.0444 (17) −0.0045 (13) 0.0032 (13) −0.0002 (13)
C5 0.0446 (17) 0.0534 (18) 0.0477 (17) −0.0074 (14) 0.0022 (14) −0.0024 (14)
C6 0.0496 (18) 0.0501 (18) 0.066 (2) −0.0033 (14) 0.0149 (16) 0.0018 (16)
C7 0.0385 (15) 0.0487 (16) 0.0418 (16) −0.0037 (13) 0.0057 (13) −0.0057 (13)
C8 0.0398 (16) 0.0513 (17) 0.0473 (17) −0.0056 (13) 0.0102 (13) −0.0028 (14)
C9 0.0413 (16) 0.0424 (15) 0.0451 (16) 0.0017 (12) 0.0040 (13) 0.0005 (13)
C10 0.0411 (16) 0.0544 (17) 0.0534 (18) −0.0026 (13) 0.0036 (14) 0.0057 (14)
C11 0.0439 (17) 0.0567 (19) 0.0519 (18) 0.0007 (14) 0.0102 (14) 0.0055 (15)
C12 0.0431 (17) 0.064 (2) 0.0477 (17) −0.0010 (14) 0.0028 (14) −0.0016 (15)
C13 0.074 (3) 0.064 (2) 0.107 (3) −0.0009 (19) −0.025 (2) −0.016 (2)
C14 0.102 (4) 0.076 (3) 0.167 (5) −0.008 (3) −0.040 (3) −0.038 (3)
C15 0.064 (3) 0.106 (3) 0.099 (3) −0.012 (2) −0.017 (2) −0.017 (3)
C16 0.0370 (15) 0.0421 (15) 0.0457 (16) 0.0013 (12) 0.0036 (12) −0.0011 (13)
C17 0.0560 (18) 0.0391 (15) 0.0517 (18) 0.0030 (13) 0.0122 (15) −0.0035 (13)
C18 0.064 (2) 0.0408 (16) 0.0592 (19) −0.0011 (14) 0.0158 (16) 0.0079 (14)
C19 0.0435 (16) 0.0520 (17) 0.0546 (18) 0.0028 (14) 0.0121 (14) 0.0045 (14)
C20 0.071 (2) 0.0532 (19) 0.075 (2) 0.0200 (16) 0.0325 (19) 0.0060 (17)
C21 0.072 (2) 0.0445 (17) 0.068 (2) 0.0130 (16) 0.0276 (18) 0.0105 (16)
C22 0.066 (2) 0.067 (2) 0.069 (2) 0.0035 (17) 0.0272 (18) 0.0094 (17)

3-[5-(4-Chlorophenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]-3-(4-methylphenyl)-1-(thiophen-2-yl)propan-1-one. Geometric parameters (Å, º)

Cl1—C1 1.740 (3) C10—C11 1.516 (4)
S1—C8 1.644 (3) C10—H10A 0.9700
S2—C15 1.664 (4) C10—H10B 0.9700
S2—C12 1.719 (3) C11—C12 1.458 (4)
O1—C8 1.371 (3) C12—C13 1.368 (5)
O1—C7 1.371 (3) C13—C14 1.420 (5)
O2—C11 1.216 (3) C13—H13 0.9300
N1—C7 1.284 (3) C14—C15 1.345 (6)
N1—N2 1.386 (3) C14—H14 0.9300
N2—C8 1.336 (3) C15—H15 0.9300
N2—C9 1.472 (3) C16—C21 1.381 (4)
C1—C2 1.373 (5) C16—C17 1.387 (4)
C1—C6 1.373 (5) C17—C18 1.380 (4)
C2—C3 1.370 (4) C17—H17 0.9300
C2—H2 0.9300 C18—C19 1.378 (4)
C3—C4 1.392 (4) C18—H18 0.9300
C3—H3 0.9300 C19—C20 1.384 (4)
C4—C5 1.381 (4) C19—C22 1.508 (4)
C4—C7 1.457 (4) C20—C21 1.381 (4)
C5—C6 1.370 (4) C20—H20 0.9300
C5—H5 0.9300 C21—H21 0.9300
C6—H6 0.9300 C22—H22A 0.9600
C9—C16 1.510 (4) C22—H22B 0.9600
C9—C10 1.523 (4) C22—H22C 0.9600
C9—H9 0.9800
C15—S2—C12 92.10 (19) H10A—C10—H10B 108.0
C8—O1—C7 106.1 (2) O2—C11—C12 121.3 (3)
C7—N1—N2 103.4 (2) O2—C11—C10 121.2 (3)
C8—N2—N1 112.4 (2) C12—C11—C10 117.5 (3)
C8—N2—C9 126.1 (2) C13—C12—C11 129.7 (3)
N1—N2—C9 121.5 (2) C13—C12—S2 111.3 (2)
C2—C1—C6 121.1 (3) C11—C12—S2 119.1 (2)
C2—C1—Cl1 119.1 (3) C12—C13—C14 110.8 (4)
C6—C1—Cl1 119.8 (3) C12—C13—H13 124.6
C3—C2—C1 119.8 (3) C14—C13—H13 124.6
C3—C2—H2 120.1 C15—C14—C13 113.2 (4)
C1—C2—H2 120.1 C15—C14—H14 123.4
C2—C3—C4 119.7 (3) C13—C14—H14 123.4
C2—C3—H3 120.1 C14—C15—S2 112.6 (3)
C4—C3—H3 120.1 C14—C15—H15 123.7
C5—C4—C3 119.6 (3) S2—C15—H15 123.7
C5—C4—C7 120.4 (3) C21—C16—C17 117.7 (3)
C3—C4—C7 119.9 (3) C21—C16—C9 121.9 (3)
C6—C5—C4 120.4 (3) C17—C16—C9 120.4 (2)
C6—C5—H5 119.8 C18—C17—C16 121.1 (3)
C4—C5—H5 119.8 C18—C17—H17 119.4
C5—C6—C1 119.4 (3) C16—C17—H17 119.4
C5—C6—H6 120.3 C19—C18—C17 121.5 (3)
C1—C6—H6 120.3 C19—C18—H18 119.2
N1—C7—O1 113.2 (2) C17—C18—H18 119.2
N1—C7—C4 128.4 (3) C18—C19—C20 117.0 (3)
O1—C7—C4 118.4 (2) C18—C19—C22 122.1 (3)
N2—C8—O1 104.9 (2) C20—C19—C22 120.9 (3)
N2—C8—S1 131.0 (2) C21—C20—C19 122.0 (3)
O1—C8—S1 124.1 (2) C21—C20—H20 119.0
N2—C9—C16 110.8 (2) C19—C20—H20 119.0
N2—C9—C10 108.9 (2) C16—C21—C20 120.6 (3)
C16—C9—C10 114.5 (2) C16—C21—H21 119.7
N2—C9—H9 107.4 C20—C21—H21 119.7
C16—C9—H9 107.4 C19—C22—H22A 109.5
C10—C9—H9 107.4 C19—C22—H22B 109.5
C11—C10—C9 111.5 (2) H22A—C22—H22B 109.5
C11—C10—H10A 109.3 C19—C22—H22C 109.5
C9—C10—H10A 109.3 H22A—C22—H22C 109.5
C11—C10—H10B 109.3 H22B—C22—H22C 109.5
C9—C10—H10B 109.3
C7—N1—N2—C8 −1.9 (3) N2—C9—C10—C11 −161.9 (2)
C7—N1—N2—C9 −179.9 (2) C16—C9—C10—C11 73.4 (3)
C6—C1—C2—C3 0.9 (5) C9—C10—C11—O2 20.9 (4)
Cl1—C1—C2—C3 −178.7 (3) C9—C10—C11—C12 −161.0 (3)
C1—C2—C3—C4 −0.1 (5) O2—C11—C12—C13 −178.0 (4)
C2—C3—C4—C5 −1.3 (5) C10—C11—C12—C13 3.9 (5)
C2—C3—C4—C7 177.8 (3) O2—C11—C12—S2 2.0 (4)
C3—C4—C5—C6 1.8 (4) C10—C11—C12—S2 −176.1 (2)
C7—C4—C5—C6 −177.3 (3) C15—S2—C12—C13 −0.6 (3)
C4—C5—C6—C1 −1.0 (4) C15—S2—C12—C11 179.4 (3)
C2—C1—C6—C5 −0.4 (5) C11—C12—C13—C14 −179.1 (4)
Cl1—C1—C6—C5 179.2 (2) S2—C12—C13—C14 0.9 (5)
N2—N1—C7—O1 1.0 (3) C12—C13—C14—C15 −1.0 (7)
N2—N1—C7—C4 179.4 (3) C13—C14—C15—S2 0.6 (7)
C8—O1—C7—N1 0.2 (3) C12—S2—C15—C14 0.0 (4)
C8—O1—C7—C4 −178.5 (2) N2—C9—C16—C21 −67.6 (3)
C5—C4—C7—N1 −21.6 (5) C10—C9—C16—C21 56.1 (4)
C3—C4—C7—N1 159.2 (3) N2—C9—C16—C17 113.2 (3)
C5—C4—C7—O1 156.8 (3) C10—C9—C16—C17 −123.1 (3)
C3—C4—C7—O1 −22.4 (4) C21—C16—C17—C18 0.6 (4)
N1—N2—C8—O1 2.0 (3) C9—C16—C17—C18 179.9 (3)
C9—N2—C8—O1 179.9 (2) C16—C17—C18—C19 −0.2 (5)
N1—N2—C8—S1 −178.3 (2) C17—C18—C19—C20 −0.7 (5)
C9—N2—C8—S1 −0.4 (4) C17—C18—C19—C22 −179.5 (3)
C7—O1—C8—N2 −1.3 (3) C18—C19—C20—C21 1.1 (5)
C7—O1—C8—S1 179.0 (2) C22—C19—C20—C21 180.0 (3)
C8—N2—C9—C16 −98.7 (3) C17—C16—C21—C20 −0.3 (5)
N1—N2—C9—C16 79.0 (3) C9—C16—C21—C20 −179.5 (3)
C8—N2—C9—C10 134.5 (3) C19—C20—C21—C16 −0.7 (5)
N1—N2—C9—C10 −47.8 (3)

3-[5-(4-Chlorophenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]-3-(4-methylphenyl)-1-(thiophen-2-yl)propan-1-one. Hydrogen-bond geometry (Å, º)

Cg3 and Cg4 are the centroids of the C1–C6 and C16–C21 rings.

D—H···A D—H H···A D···A D—H···A
C20—H20···Cg3i 0.93 2.83 3.726 (3) 164
C22—H22B···Cg4ii 0.96 2.92 3.671 (4) 136

Symmetry codes: (i) x, −y+1, z+1/2; (ii) −x+1/2, −y+1/2, −z+2.

References

  1. Al-Alshaikh, M. A., Abuelizz, H. A., El-Emam, A. A., Abdelbaky, M. S. M. & Garcia-Granda, S. (2016). Acta Cryst. E72, 269–272. [DOI] [PMC free article] [PubMed]
  2. Alisi, I. O., Uzairu, A. & Abechi, S. E. (2020). Heliyon6, e03683. [DOI] [PMC free article] [PubMed]
  3. Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 216, S1–S19.
  4. Al-Omary, F. A. M., AlRabiah, H., Ghabbour, H. A., Quah, C. K., Fun, H.-K. & El-Emam, A. A. (2015a). Z. Krist.-New Cryst. Struct.230, 267–268.
  5. Al-Omary, F. A. M., El-Emam, A. A., Ghabbour, H. A., Chidan Kumar, C. S., Quah, C. K. & Fun, H.-K. (2015b). Acta Cryst. E71, o175–o176. [DOI] [PMC free article] [PubMed]
  6. Al-Wahaibi, L. H., Blacque, O., Tiekink, E. R. T. & El-Emam, A. A. (2025). Z. Krist. New Cryst. Struct.240, 491–493.
  7. Arshad, M. N., Al-Dies, A. M., Asiri, A. M., Khalid, M., Birinji, A. S., Al-Amry, K. A. & Braga, A. A. (2017). J. Mol. Struct.1141, 142–156.
  8. Bhukta, S., Chatterjee, R., Angajala, K. K. & Dandela, R. (2023). Tetrahedron Lett.128, 154714.
  9. Boström, J., Hogner, A., Llinàs, A., Wellner, E. & Plowright, A. T. (2012). J. Med. Chem.55, 1817–1830. [DOI] [PubMed]
  10. Bruker (2021). APEX4, SAINT and XPREP. Bruker AXS Inc., Madison, Wisconsin, USA.
  11. Burcu Arslan, N., Özdemir, N., Dayan, O., Dege, N., Koparır, M., Koparır, P. & Muğlu, H. (2014). Chem. Phys.439, 1–11.
  12. Chantrapromma, S., Ruanwas, P., Boonnak, N. & Fun, H.-K. (2013). Acta Cryst. E69, o1004–o1005. [DOI] [PMC free article] [PubMed]
  13. da Silva, P. T., da Silva Mendes, F. R., Almeida-Neto, F. W. Q., Marinho, E. S., da Silva, L., da Silva Julião, M. S., Marinho, M. M., Vidal, L. M. T., Ayala, A. P., Coutinho, H. D. M., Rocha, J. E., Gomes, A. O. C. V., Lucio, F. N. M., Guedes, J. M., Teixeira, A. M. R. & Silva dos Santos, H. (2024). J. Mol. Struct.1312, 138497.
  14. El-Emam, A. A., Al-Omar, M. A., Al-Obaid, A.-R. M., Ng, S. W. & Tiekink, E. R. T. (2013). Acta Cryst. E69, o684. [DOI] [PMC free article] [PubMed]
  15. El-Emam, A. A., Al-Omar, M. A., Ghabbour, H. A., Fun, H.-K. & Chia, T. S. (2012). Acta Cryst. E68, o1345–o1346. [DOI] [PMC free article] [PubMed]
  16. Farrugia, L. J. (2012). J. Appl. Cryst.45, 849–854.
  17. Groom, C. R., Bruno, I. J., Lightfoot, M. P. & Ward, S. C. (2016). Acta Cryst. B72, 171–179. [DOI] [PMC free article] [PubMed]
  18. Kadi, A. A., El-Brollosy, N. R., Al-Deeb, O. A., Habib, E. E., Ibrahim, T. M. & El-Emam, A. A. (2007). Eur. J. Med. Chem.42, 235–242. [DOI] [PubMed]
  19. Karanth, S. N., Narayana, B., Sarojini, B. K., Kumar, S. M. & Byrappa, K. (2019). Chem. Data Collect.19, 100179.
  20. Kumar, R., Hussain, S., Khan, K. M., Perveen, S. & Yousuf, S. (2017). Acta Cryst. E73, 524–527. [DOI] [PMC free article] [PubMed]
  21. Palaska, E., Şahin, G., Kelicen, P., Durlu, N. T. & Altinok, G. (2002). Farmaco57, 101–107. [DOI] [PubMed]
  22. Patel, K. D., Prajapati, S. M., Panchal, S. N. & Patel, H. D. (2014). Synth. Commun.44, 1859–1875.
  23. Pugh, D. S., Wood, N. J., Whitwood, A. C., Parker, R. R., Mills, A. L. F., Aspell, A. M., Coyne, E., Hill, I. A. & Latter, R. C. (2019). CSD Communication (refcode ZOVPOS). CCDC, Cambridge, England.
  24. Salahuddin, A. M., Mazumder, A., Yar, M. S., Mazumder, R., Chakraborthy, G. S., Ahsan, M. J. & Rahman, M. U. (2017). Synth. Commun.47, 1805–1847.
  25. Shalaby, M. A., Rizk, S. A. & Fahim, A. M. (2023). Org. Biomol. Chem.21, 5317–5346. [DOI] [PubMed]
  26. Sharma, P., Subbulakshmi, K. N., Narayana, B., Sarojini, B. K. & Kant, R. (2016). Crystallogr. Rep.61, 230–233.
  27. Sheldrick, G. M. (2015a). Acta Cryst. A71, 3–8.
  28. Sheldrick, G. M. (2015b). Acta Cryst. C71, 3–8.
  29. Shih, M. H. (2004). Synthesis 26–32.
  30. Spackman, P. R., Turner, M. J., McKinnon, J. J., Wolff, S. K., Grimwood, D. J., Jayatilaka, D. & Spackman, M. A. (2021). J. Appl. Cryst.54, 1006–1011. [DOI] [PMC free article] [PubMed]
  31. Sweeting, S. G., Hall, C. L., Potticary, J., Pridmore, N. E., Warren, S. D., Cremeens, M. E., D’Ambruoso, G. D., Matsumoto, M. & Hall, S. R. (2020). Acta Cryst. B76, 13–17. [DOI] [PubMed]
  32. Zhang, Q. L., Sun, L. T., Yang, X. J., Zu, H., Li, L. L., Yang, X. S. & Hu, W. (2021). Wuji Huaxue Xuebao37, 989–994.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S2056989026008819/yz2084sup1.cif

e-82-01107-sup1.cif (1.6MB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989026008819/yz2084Isup2.hkl

e-82-01107-Isup2.hkl (305.3KB, hkl)
e-82-01107-Isup3.cml (7.5KB, cml)

Supporting information file. DOI: 10.1107/S2056989026008819/yz2084Isup3.cml

CCDC reference: 2583252

Additional supporting information: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Crystallographic Communications are provided here courtesy of International Union of Crystallography

RESOURCES